Article
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics - 1 Oct 2018
Rodriguez-Perez Ana I, Sucunza Diego, Pedrosa Maria A, Garrido-Gil Pablo, Kulisevsky Jaime, Lanciego Jose L, Labandeira-Garcia Jose L
Abstract excerpt
The loss of dopaminergic neurons and α-synuclein accumulation are major hallmarks of Parkinson's disease (PD), and it has been suggested that a major mechanism of α-synuclein toxicity is microglial activation. The lack of animal models that properly reproduce PD, and particularly the underlying synucleinopathy, has hampered the clarification of PD mechanisms and the development of effective therapies. Here, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
